Suppr超能文献

布比卡因-芬太尼混合液骶管注射用于儿童的镇痛效果及安全性

Analgesic efficacy and safety of a caudal bupivacaine-fentanyl mixture in children.

作者信息

Campbell F A, Yentis S M, Fear D W, Bissonnette B

机构信息

Department of Anaesthesia, Hospital for Sick Children, University of Toronto, Ontario, Canada.

出版信息

Can J Anaesth. 1992 Sep;39(7):661-4. doi: 10.1007/BF03008226.

Abstract

The analgesic efficacy and safety of a single caudal injection of a bupivacaine-fentanyl mixture was investigated in this prospective, controlled, triple-blinded study of 34 children, aged 1-11 yr and of ASA physical status I-II undergoing urological surgery. After induction of anaesthesia and before surgery, the children were randomly assigned to receive a caudal injection of 1.0 ml.kg-1 bupivacaine 0.125% with epinephrine 1:400,000 and either fentanyl 1.0 microgram.kg-1 in 1.0 ml of normal saline or 1.0 ml of normal saline. After completion of surgery, patients were assessed in the recovery room for six hours from the time of the caudal injection and for a further 18 hr on the ward. While in the recovery room arterial oxygen saturation and respiratory rate were monitored continuously and recorded hourly together with end-tidal carbon dioxide, pain and sedation scores. Other complications were also recorded. While on the ward, pain and sedation scores, respiratory rate and side effects were recorded every two hours. Postoperative analgesia was provided by intravenous morphine. Analgesic requirements were recorded for the 24-hr study period. Pain and sedation scores did not differ between groups. Respiratory depression or hypoxia did not occur. The incidences of other side effects did not differ. There were no differences in the numbers of patients requiring morphine within eight hours, the time to first morphine administration or the total morphine requirements. We conclude that a single caudal injection of a bupivacaine-fentanyl mixture with epinephrine administered prior to surgery, while safe, offers no advantage over an injection of bupivacaine 0.125% with epinephrine for paediatric urological surgery.

摘要

在这项针对34名年龄在1至11岁、ASA身体状况为I-II级且接受泌尿外科手术的儿童进行的前瞻性、对照、三盲研究中,对单次骶管注射布比卡因-芬太尼混合物的镇痛效果和安全性进行了调查。在麻醉诱导后和手术前,将儿童随机分为两组,分别接受骶管注射1.0 ml·kg-1的0.125%布比卡因加1:400,000肾上腺素,以及在1.0 ml生理盐水中加入1.0 μg·kg-1芬太尼或1.0 ml生理盐水。手术结束后,在恢复室对患者从骶管注射时起进行6小时评估,并在病房再评估18小时。在恢复室期间,持续监测动脉血氧饱和度和呼吸频率,每小时记录一次,同时记录呼气末二氧化碳、疼痛和镇静评分。还记录其他并发症。在病房时,每两小时记录一次疼痛和镇静评分、呼吸频率及副作用。术后镇痛采用静脉注射吗啡。记录24小时研究期间的镇痛需求。两组之间的疼痛和镇静评分无差异。未发生呼吸抑制或低氧血症。其他副作用的发生率也无差异。在8小时内需要吗啡的患者数量、首次使用吗啡的时间或吗啡总需求量均无差异。我们得出结论,术前单次骶管注射含肾上腺素的布比卡因-芬太尼混合物虽然安全,但对于小儿泌尿外科手术而言,并不比注射0.125%布比卡因加肾上腺素更具优势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验